BioSpace News Archive

Societal CDMO, Inc. announced that the company closed its previously announced underwritten public offering of 20,750,000 shares of its common stock at a public offering price of $0.40 per share of common stock on Monday, August 28, 2023.

TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from residual cancer detection to genetic toxicology announced the appointment of Ron Andrews, as Chief Executive Officer and Board Member.

Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their ‘Human T Cell Activation & Expansion Kit’ with Buoyancy Activated Cell Sorting (BACS) microbubbles.

CobiCure Medical Technologies announced today its continued commitment to solving the unmet needs in pediatric medical technologies with a grant of strategic support, resources, and $2 million in funding to PolyVascular, a Houston,TX based medical device company, developing a transformative, first of its kind, non-surgical heart valve for young children suffering from congenital heart disease.

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the general availability of Linea™ IVT platform evaluation kits (the “Kit”) and the first shipment of a Kit to an existing Linea™ IVT Template customer.

Radiaction Medical, LTD, a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, made two announcements.

Marrow Access Technologies announced today that it signed a distribution agreement with Spartan Medical.

The Lung Cancer Research Foundation is pleased to announce the appointment of a select group of volunteers as its Research Advocates.

Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx™" or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome Ivory Chang as the Company’s Chief Regulatory Affairs Officer.

Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services